Display options
Cite
Lotan C, Bakst A, Rozenman Y, et al. Initial and long-term results with the CrossFlex stent--data from a national registry. Int J Cardiovasc Intervent. 1999;2(4):237-240doi: 10.1080/acc.2.4.237.240.
Lotan, C., Bakst, A., Rozenman, Y., Miller, H., Beyar, R., Pardes, A., Herz, I., Tamari, I., Ayzenberg, O., Iliah, R., Peled, B., Hendler, A., & Banai, S. (1999). Initial and long-term results with the CrossFlex stent--data from a national registry. International journal of cardiovascular interventions, 2(4), 237-240. https://doi.org/10.1080/acc.2.4.237.240
Lotan, C, et al. "Initial and long-term results with the CrossFlex stent--data from a national registry." International journal of cardiovascular interventions vol. 2,4 (1999): 237-240. doi: https://doi.org/10.1080/acc.2.4.237.240
Lotan C, Bakst A, Rozenman Y, Miller H, Beyar R, Pardes A, Herz I, Tamari I, Ayzenberg O, Iliah R, Peled B, Hendler A, Banai S. Initial and long-term results with the CrossFlex stent--data from a national registry. Int J Cardiovasc Intervent. 1999;2(4):237-240. doi: 10.1080/acc.2.4.237.240. PMID: 12623574.
Copy Download .nbib Format: NLM
Share it on

Int J Cardiovasc Intervent. 1999;2(4):237-240. doi: 10.1080/acc.2.4.237.240.

Initial and long-term results with the CrossFlex stent--data from a national registry.

International journal of cardiovascular interventions

C Lotan, A Bakst, Y Rozenman, H Miller, R Beyar, A Pardes, I Herz, I Tamari, O Ayzenberg, R Iliah, B Peled, A Hendler, S Banai

Affiliations

  1. The Israeli Working Group, for Interventional Cardiology.

PMID: 12623574 DOI: 10.1080/acc.2.4.237.240

Abstract

The Cordis CrossFlex trade mark stent is a balloon expandable helical coil made of stainless steel. OBJECTIVE: To assess the short- and long-term safety and efficacy of this stent by conducting a multi-center national registry. METHODS: One hundred and sixteen stents were implanted in 109 patients (mean age 59 3 10 years, 95 males). The lesions were classified as type B2 or C in 56 patients (51%). Successful deployment was achieved in 103 patients (94.5%). Failure was due to damage to the stent (two patients) or inability to reach the lesion (four patients). High-pressure deployment (>14 atm) was used in 68% of cases. RESULTS: Edge dissections occurred in nine patients after high-pressure deployment and necessitated implantation of a second stent. One patient with a large acute myocardial infarction died during hospitalization. Side branch occlusion occurred in five patients (4.6%). Subacute thrombosis occurred in two patients (1.8%) during the first four weeks. During a six-month follow-up period, 18 patients (16.5%) were rehospitalized with recurrent angina. Fifteen patients had coronary angiography and 13 (12.1%) needed additional target lesion revascularization (TLR). Twelve patients required a second PTCA for in-stent restenosis, and one needed a coronary artery bypass graft operation. CONCLUSIONS: The CrossFlex coronary stent can successfully be used in complex coronary lesions, with few short-term complications and a low TLR rate. Operators should be aware of the possibility of edge dissection during high-pressure implantation.

Publication Types